Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).
In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).
MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.
MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.
Choose MenaQ7® to support your heart health claims with science!
Latest news & videos
- Corporate
- Digestion & Gut
- News
- Mar 20, 2025
Looking Back at the Solidarity Conference on Digestive Health
On Tuesday, the solidarity conference organized by the foundation Digestscience on "Physical Activity, Gut...
- MenaQ7®
- Mobility & Joint
- Mythocondro®
- Mar 17, 2025
Exciting Insights into Longevity:
Vital Nutrients Symposium 2025 Is Just Around the Corner
The countdown has begun for the Vital Nutrients Symposium 2025, which will take place...
- Emothion®
- News
- Wellness & Immune
- Mar 12, 2025
Safety of S-Acetyl Glutathione confirmed for food and dietary supplements
Celebrating a new milestone: Safety assessment of S-Acetyl Glutathione for food and dietary supplement...
